152 related articles for article (PubMed ID: 37502912)
1. Oncostatin M is a Master Regulator of an Inflammatory Network in
Schwartz LS; Young KA; Stearns TM; Boyer N; Mujica KD; Trowbridge JJ
bioRxiv; 2023 Jul; ():. PubMed ID: 37502912
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional and functional consequences of Oncostatin M signaling on young Dnmt3a-mutant hematopoietic stem cells.
Schwartz LS; Young KA; Stearns TM; Boyer N; Mujica KD; Trowbridge JJ
Exp Hematol; 2024 Feb; 130():104131. PubMed ID: 38000729
[TBL] [Abstract][Full Text] [Related]
3. Txnip Enhances Fitness of Dnmt3a-Mutant Hematopoietic Stem Cells via p21.
Zhang CR; Ostrander EL; Kukhar O; Mallaney C; Sun J; Haussler E; Celik H; Koh WK; King KY; Gontarz P; Challen GA
Blood Cancer Discov; 2022 May; 3(3):220-239. PubMed ID: 35394496
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis.
Zioni N; Bercovich AA; Chapal-Ilani N; Bacharach T; Rappoport N; Solomon A; Avraham R; Kopitman E; Porat Z; Sacma M; Hartmut G; Scheller M; Muller-Tidow C; Lipka D; Shlush E; Minden M; Kaushansky N; Shlush LI
Nat Commun; 2023 Apr; 14(1):2070. PubMed ID: 37045808
[TBL] [Abstract][Full Text] [Related]
5. Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling.
Hormaechea-Agulla D; Matatall KA; Le DT; Kain B; Long X; Kus P; Jaksik R; Challen GA; Kimmel M; King KY
Cell Stem Cell; 2021 Aug; 28(8):1428-1442.e6. PubMed ID: 33743191
[TBL] [Abstract][Full Text] [Related]
6. Aging-elevated inflammation promotes DNMT3A R878H-driven clonal hematopoiesis.
Liao M; Chen R; Yang Y; He H; Xu L; Jiang Y; Guo Z; He W; Jiang H; Wang J
Acta Pharm Sin B; 2022 Feb; 12(2):678-691. PubMed ID: 35256939
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization.
Bisht K; McGirr C; Lee SY; Tseng HW; Fleming W; Alexander KA; Matsumoto T; Barbier V; Sims NA; Müller-Newen G; Winkler IG; Bonig H; Lévesque JP
Leukemia; 2022 Feb; 36(2):333-347. PubMed ID: 34518644
[TBL] [Abstract][Full Text] [Related]
8. Hematologic DNMT3A reduction and high-fat diet synergize to promote weight gain and tissue inflammation.
Reyes JM; Tovy A; Zhang L; Bortoletto AS; Rosas C; Chen CW; Waldvogel SM; Guzman AG; Aguilar R; Gupta S; Liu L; Buckley MT; Patel KR; Marcogliese AN; Li Y; Curry CV; Rando T; Brunet A; Parchem RJ; Rau RE; Goodell MA
iScience; 2024 Mar; 27(3):109122. PubMed ID: 38414863
[TBL] [Abstract][Full Text] [Related]
9. Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss.
Wang H; Divaris K; Pan B; Li X; Lim JH; Saha G; Barovic M; Giannakou D; Korostoff JM; Bing Y; Sen S; Moss K; Wu D; Beck JD; Ballantyne CM; Natarajan P; North KE; Netea MG; Chavakis T; Hajishengallis G
Cell; 2024 May; ():. PubMed ID: 38838669
[TBL] [Abstract][Full Text] [Related]
10. Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo.
Jeong M; Park HJ; Celik H; Ostrander EL; Reyes JM; Guzman A; Rodriguez B; Lei Y; Lee Y; Ding L; Guryanova OA; Li W; Goodell MA; Challen GA
Cell Rep; 2018 Apr; 23(1):1-10. PubMed ID: 29617651
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
[TBL] [Abstract][Full Text] [Related]
12. Dnmt3a-null hematopoietic stem and progenitor cells expand after busulfan treatment.
Chen J; Matatall KA; Feng X; Hormaechea-Agulla D; Maharjan M; Young N; King KY
Exp Hematol; 2020 Nov; 91():39-45.e2. PubMed ID: 32961298
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M maintains the hematopoietic microenvironment in the bone marrow by modulating adipogenesis and osteogenesis.
Sato F; Miyaoka Y; Miyajima A; Tanaka M
PLoS One; 2014; 9(12):e116209. PubMed ID: 25551451
[TBL] [Abstract][Full Text] [Related]
14. Targeted disruption of oncostatin M receptor results in altered hematopoiesis.
Tanaka M; Hirabayashi Y; Sekiguchi T; Inoue T; Katsuki M; Miyajima A
Blood; 2003 Nov; 102(9):3154-62. PubMed ID: 12855584
[TBL] [Abstract][Full Text] [Related]
15. Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response.
Scheller M; Ludwig AK; Göllner S; Rohde C; Krämer S; Stäble S; Janssen M; Müller JA; He L; Bäumer N; Arnold C; Gerß J; Schönung M; Thiede C; Niederwieser C; Niederwieser D; Serve H; Berdel WE; Thiem U; Hemmerling I; Leuschner F; Plass C; Schlesner M; Zaugg J; Milsom MD; Trumpp A; Pabst C; Lipka DB; Müller-Tidow C
Nat Cancer; 2021 May; 2(5):527-544. PubMed ID: 35122024
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin m regulates mesenchymal cell differentiation and enhances hematopoietic supportive activity of bone marrow stromal cell lines.
Yanai N; Obinata M
In Vitro Cell Dev Biol Anim; 2001; 37(10):698-704. PubMed ID: 11776976
[TBL] [Abstract][Full Text] [Related]
18. Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion.
Tovy A; Reyes JM; Gundry MC; Brunetti L; Lee-Six H; Petljak M; Park HJ; Guzman AG; Rosas C; Jeffries AR; Baple E; Mill J; Crosby AH; Sency V; Xin B; Machado HE; Castillo D; Weitzel JN; Li W; Stratton MR; Campbell PJ; Wang H; Sanders MA; Goodell MA
Cell Stem Cell; 2020 Aug; 27(2):326-335.e4. PubMed ID: 32673568
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin m maintains the hematopoietic microenvironment and retains hematopoietic progenitors in the bone marrow.
Minehata K; Takeuchi M; Hirabayashi Y; Inoue T; Donovan PJ; Tanaka M; Miyajima A
Int J Hematol; 2006 Nov; 84(4):319-27. PubMed ID: 17118758
[TBL] [Abstract][Full Text] [Related]
20. Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis.
Loberg MA; Bell RK; Goodwin LO; Eudy E; Miles LA; SanMiguel JM; Young K; Bergstrom DE; Levine RL; Schneider RK; Trowbridge JJ
Leukemia; 2019 Jul; 33(7):1635-1649. PubMed ID: 30692594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
